In 2021, a Northwestern University-led research team received a Defense Advanced Research Projects Agency (DARPA) contract worth up to $33 million to develop an implantable “living pharmacy” to control the human body’s sleep/wake cycles.
New device could keep implantable “living pharmacy” cells alive for months
- Post author:
- Post published:November 9, 2023
- Post category:uncategorized